ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy
Lung Cancer Considered5 Kesä

ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy

In this Part 1 of 2 ASCO 2026 Highlights episodes, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Alice Shaw and Dr. Jonathan Goldman to review some of the most impactful targeted therapy data presented at the 2026 ASCO Annual Meeting. The discussion explores the practice-changing LIBRETTO-432 trial in early-stage RET-positive NSCLC, long-term outcomes with lorlatinib in ALK-positive disease, emerging data for neladalkib, and promising results for sunvozertinib in EGFR exon 20 insertion–positive NSCLC, highlighting how these findings may influence treatment decisions across disease stages. Guests: Dr. Alice Shaw. is a Professor of Medicine at Harvard Medical School, Chair of Medical Oncology, and a thoracic oncologist at Dana Farber Cancer Institute. She is widely recognized as a pioneer in the field of ALK-positive non-small cell lung cancer, having led landmark clinical trials that established crizotinib, ceritinib, and lorlatinib as standards of care. Dr. Jonathan W. Goldman is a Professor of Medicine and thoracic oncologist at the UCLA David Geffen School of Medicine, where he serves as a principal investigator in the Phase I drug development program. Dr. Goldman has been at the forefront of early-phase oncology trials across multiple tumor types, with a particular focus on novel therapeutics in lung cancer, and he was the presenting author of Libretto 432 at the plenary session at the 2026 ASCO

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(416)

WCLC 2026 Early Career Takeover: Research, Networking, and Career Growth

WCLC 2026 Early Career Takeover: Research, Networking, and Career Growth

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of t...

13 Loka 18min

LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026

LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026

The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To ad...

9 Loka 37min

LCC in Korean WCLC 2026 Highlights

LCC in Korean WCLC 2026 Highlights

The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC ha...

6 Loka 45min

WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care

WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care

In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and con...

5 Loka 24min

WCLC 2026 East-West Academic Exchange: Collaborating on the Future of Lung Cancer Care

WCLC 2026 East-West Academic Exchange: Collaborating on the Future of Lung Cancer Care

Recorded live at the IASLC World Conference on Lung Cancer (WCLC) 2026 in Seoul, this episode brings together experts from China and the U.S. to discuss the growing exchange of ideas, research, and cl...

1 Loka 34min

WCLC 2026 Nurse Practitioner Takeover: What APPs are Taking Back to the Clinic

WCLC 2026 Nurse Practitioner Takeover: What APPs are Taking Back to the Clinic

Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Nurse Practitioner takeover episode looks at key developments in small cell lung cancer, antibody-drug conjugates, and...

29 Syys 44min

LCC in Czech: WCLC 2026 Highlights

LCC in Czech: WCLC 2026 Highlights

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASL...

24 Syys 10min

LCC in Spanish: WCLC 2026 Highlights

LCC in Spanish: WCLC 2026 Highlights

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC...

17 Syys 48min

Suosittua kategoriassa Tiede

tiedekulma-podcast
utelias-mieli
rss-mita-tulisi-tietaa
rss-duodecim-lehti
rss-hereilla
docemilia
rss-kasvikutsut
rss-vaasan-yliopiston-podcastit
rss-radplus